US5916588A
(en)
*
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
US6090406A
(en)
*
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
US5192528A
(en)
*
|
1985-05-22 |
1993-03-09 |
Liposome Technology, Inc. |
Corticosteroid inhalation treatment method
|
NZ221411A
(en)
*
|
1986-08-11 |
1989-10-27 |
Innovata Biomed Ltd |
Pharmaceutical compositions containing microcapsules and a surfactant
|
SE8603812D0
(sv)
*
|
1986-09-12 |
1986-09-12 |
Draco Ab |
Administration of liposomes to mammals
|
IE63869B1
(en)
*
|
1986-11-06 |
1995-06-14 |
Res Dev Foundation |
Aerosols containing liposomes and method for their preparation
|
US5089181A
(en)
*
|
1987-02-24 |
1992-02-18 |
Vestar, Inc. |
Method of dehydrating vesicle preparations for long term storage
|
JP2770970B2
(ja)
*
|
1987-04-09 |
1998-07-02 |
フアイソンズ・ピーエルシー |
ペンタミジンを含有する医薬組成物
|
JP2656944B2
(ja)
*
|
1987-04-30 |
1997-09-24 |
クーパー ラボラトリーズ |
タンパク質性治療剤のエアロゾール化
|
DE3853079T3
(de)
*
|
1987-12-04 |
2000-11-09 |
Liposome Co Inc |
Liposome hoher stabilität und verfahren zur herstellung und verwendung.
|
AU5194990A
(en)
*
|
1989-02-23 |
1990-09-26 |
Rorer International (Holdings), Inc. |
Therapeutic aerosol formulations
|
US5174988A
(en)
*
|
1989-07-27 |
1992-12-29 |
Scientific Development & Research, Inc. |
Phospholipid delivery system
|
AU6428890A
(en)
*
|
1989-09-12 |
1991-04-18 |
Regents Of The University Of California, The |
Therapeutic peptides and proteins
|
US5305757A
(en)
*
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US20020150539A1
(en)
*
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US5656211A
(en)
*
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US5705187A
(en)
*
|
1989-12-22 |
1998-01-06 |
Imarx Pharmaceutical Corp. |
Compositions of lipids and stabilizing materials
|
US6001335A
(en)
*
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US5585112A
(en)
*
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5922304A
(en)
*
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
US5542935A
(en)
*
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
GB9001019D0
(en)
*
|
1990-01-17 |
1990-03-14 |
Euro Celtique Sa |
Pharmaceutical aerosol
|
US5162361A
(en)
*
|
1990-04-10 |
1992-11-10 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Method of treating diseases associated with elevated levels of interleukin 1
|
US5370862A
(en)
*
|
1990-06-13 |
1994-12-06 |
Schwarz Pharma Ag |
Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina
|
US5258289A
(en)
*
|
1990-09-05 |
1993-11-02 |
Davis Claude G |
Method for the selecting of genes encoding catalytic antibodies
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US5874062A
(en)
*
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5993805A
(en)
*
|
1991-04-10 |
1999-11-30 |
Quadrant Healthcare (Uk) Limited |
Spray-dried microparticles and their use as therapeutic vehicles
|
US5683714A
(en)
*
|
1991-04-19 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Liposomal cyclosporin pharmaceutical formulation
|
US5457100A
(en)
*
|
1991-12-02 |
1995-10-10 |
Daniel; David G. |
Method for treatment of recurrent paroxysmal neuropsychiatric
|
US5639441A
(en)
*
|
1992-03-06 |
1997-06-17 |
Board Of Regents Of University Of Colorado |
Methods for fine particle formation
|
US5814666A
(en)
*
|
1992-04-13 |
1998-09-29 |
The United States As Represented By The Department Of Health And Human Services |
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US5350359A
(en)
*
|
1992-07-16 |
1994-09-27 |
Temple University Of The Commonwealth System Of Higher Education |
Control, treatment and/or diagnosis of physiological conditions with degassed perfluorocarbon liquid
|
JP3717925B2
(ja)
*
|
1992-09-29 |
2005-11-16 |
ネクター セラピューティクス |
副甲状腺ホルモンの活性フラグメントの肺導入
|
WO1994017538A2
(en)
*
|
1993-01-21 |
1994-08-04 |
Mayo Foundation For Medical Education And Research |
Microparticle switching devices
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US5441060A
(en)
*
|
1993-02-08 |
1995-08-15 |
Duke University |
Dry powder delivery system
|
US5654006A
(en)
*
|
1993-02-12 |
1997-08-05 |
Mayo Foundation For Medical Education And Research |
Condensed-phase microparticle composition and method
|
US5593661A
(en)
*
|
1993-03-29 |
1997-01-14 |
Henry; Richard A. |
Lidocaine aerosol anaesthetic
|
AU732440B2
(en)
*
|
1993-06-11 |
2001-04-26 |
Imarx Pharmaceutical Corp. |
Novel therapeutic delivery systems
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
EP0706374B1
(de)
*
|
1993-06-30 |
1997-12-10 |
Genentech, Inc. |
Verfahren zur herstellung von liposomen
|
AU7972294A
(en)
*
|
1993-10-07 |
1995-05-01 |
Entremed, Inc |
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
|
US5994339A
(en)
*
|
1993-10-15 |
1999-11-30 |
University Of Alabama At Birmingham Research Foundation |
Oxidant scavengers
|
US6127356A
(en)
|
1993-10-15 |
2000-10-03 |
Duke University |
Oxidant scavengers
|
US5747026A
(en)
*
|
1993-10-15 |
1998-05-05 |
University Of Alabama At Birmingham Research Foundation |
Antioxidants
|
US7083572B2
(en)
*
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
DE4402867C1
(de)
*
|
1994-01-31 |
1995-06-14 |
Rentschler Arzneimittel |
Liposomen enthaltend darin verkapselte Proteine, Verfahren zu ihrer Herstellung sowie diese Liposomen enthaltende pharmazeutische und kosmetische Zubereitungen
|
US6312719B1
(en)
*
|
1994-03-04 |
2001-11-06 |
The University Of British Columbia |
Liposome compositions and methods for the treatment of atherosclerosis
|
US6773719B2
(en)
|
1994-03-04 |
2004-08-10 |
Esperion Luv Development, Inc. |
Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias
|
WO1995024183A1
(en)
*
|
1994-03-07 |
1995-09-14 |
Inhale Therapeutic Systems |
Methods and compositions for pulmonary delivery of insulin
|
US6102036A
(en)
*
|
1994-04-12 |
2000-08-15 |
Smoke-Stop |
Breath activated inhaler
|
US5451569A
(en)
*
|
1994-04-19 |
1995-09-19 |
Hong Kong University Of Science And Technology R & D Corporation Limited |
Pulmonary drug delivery system
|
EP0759939B1
(de)
*
|
1994-05-18 |
2005-07-20 |
Nektar Therapeutics |
Methoden und zusammensetzungen für die trockenpuderarznei aus interferonen
|
US5736121A
(en)
*
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
AU3758695A
(en)
*
|
1994-09-20 |
1996-04-09 |
Duke University |
Oxidoreductase activity of manganic porphyrins
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
SE9404468D0
(sv)
*
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
PL321094A1
(en)
|
1994-12-22 |
1997-11-24 |
Astra Ab |
Parathyroid hormone (pth) containing preparation administered by inhalation
|
JP4155594B2
(ja)
|
1994-12-22 |
2008-09-24 |
アストラゼネカ・アクチエボラーグ |
エアゾール製剤
|
US6518397B1
(en)
|
1997-07-24 |
2003-02-11 |
Shoukat Dedhar |
Pharmaceuticals for modulating hormone responsiveness
|
US5854202A
(en)
*
|
1995-01-24 |
1998-12-29 |
Dedhar; Shoukat |
Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same
|
US5830430A
(en)
*
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
CA2218879A1
(en)
*
|
1995-05-12 |
1996-11-14 |
Genentech, Inc. |
Coarse spray delivery of functional biologic materials
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US5693336A
(en)
*
|
1995-06-07 |
1997-12-02 |
Nexstar Pharmaceuticals, Inc. |
Blood stable liposomal cyclosporin formulations
|
US6139819A
(en)
*
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US5603918A
(en)
*
|
1995-06-09 |
1997-02-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aerosol composition of a salt of ipratropium and a salt of albuterol
|
ATE345682T1
(de)
|
1996-05-01 |
2006-12-15 |
Imarx Pharmaceutical Corp |
In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
|
US20020052310A1
(en)
*
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
GB9615350D0
(en)
*
|
1996-07-22 |
1996-09-04 |
Resource Medical Limited |
Hormone replacement therapy
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
ES2289188T3
(es)
*
|
1996-09-11 |
2008-02-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Procedimiento para la obtencion de imagenes para el diagnostico usando un agente de contraste y un vasodilatador.
|
US5846517A
(en)
*
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
BR9713661A
(pt)
*
|
1996-12-30 |
2000-10-24 |
Battelle Memorial Institute |
Formulação e método para o tratamento de neoplasmas por inalação
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6537246B1
(en)
*
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US20050019266A1
(en)
*
|
1997-05-06 |
2005-01-27 |
Unger Evan C. |
Novel targeted compositions for diagnostic and therapeutic use
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US20020039594A1
(en)
*
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US7179615B1
(en)
*
|
1997-07-29 |
2007-02-20 |
Menzies School Of Health Research |
Method of prophylaxis and treatment
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
EP1019021B2
(de)
*
|
1997-09-29 |
2012-12-26 |
Novartis AG |
In dosierinhalatoren verwendbare, stabilisierte zubereitungen
|
WO1999023097A1
(en)
|
1997-11-03 |
1999-05-14 |
Duke University |
Substituted porphyrins
|
WO1999024016A1
(en)
*
|
1997-11-10 |
1999-05-20 |
Sonus Pharmaceuticals, Inc. |
Emulsions for aerosolization and drug delivery
|
DE69810355T2
(de)
*
|
1997-12-03 |
2003-10-30 |
Britannia Pharmaceuticals Ltd |
Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
DE69928655T2
(de)
|
1998-04-24 |
2006-08-24 |
Duke University |
Substituierte porphyrine
|
US6956021B1
(en)
*
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US6703384B2
(en)
|
1998-09-23 |
2004-03-09 |
Research Development Foundation |
Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
|
US8933032B2
(en)
|
1998-10-20 |
2015-01-13 |
Children's Hospital Medical Center |
Surfactant protein D for the treatment of disorders associated with lung injury
|
AU766703B2
(en)
*
|
1998-11-12 |
2003-10-23 |
Frank G Pilkiewicz |
An inhalation system
|
EP1839648A3
(de)
*
|
1998-11-12 |
2007-11-21 |
Transave, Inc. |
Inhalationssystem
|
GB9912639D0
(en)
*
|
1999-05-28 |
1999-07-28 |
Britannia Pharmaceuticals Ltd |
Improvements in and relating to treatment of respiratory conditions
|
AU779283B2
(en)
*
|
1999-01-25 |
2005-01-13 |
Aeolus Sciences, Inc. |
Substituted porphyrins
|
WO2000045878A2
(de)
|
1999-02-03 |
2000-08-10 |
Max-Delbrück-Centrum für Molekulare Medizin |
Druckluftinhalator zur pulmonalen applikation liposomalen pulver-aerosols sowie dafür geeignete pulver-aerosole
|
US20050196345A1
(en)
*
|
1999-02-03 |
2005-09-08 |
Max-Delbruck-Centrum Fur Molekulare Medizin |
Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols
|
US6521212B1
(en)
*
|
1999-03-18 |
2003-02-18 |
United Therapeutics Corporation |
Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
US7258850B2
(en)
*
|
1999-05-04 |
2007-08-21 |
Aradigm Corporation |
Methods and compositions for treating erectile dysfunction
|
EP1183011A4
(de)
*
|
1999-05-14 |
2005-01-19 |
Esperion Luv Dev Inc |
Verfahren zur behandlung von angina und/oder anginaähnlichen erkrankungen sowie die diesbezüglichen arzneimittel und kits
|
CA2375371A1
(en)
*
|
1999-06-04 |
2000-12-14 |
Skyepharma Inc. |
Oil-core compositions for the sustained release of hydrophobic drugs
|
BR0011343A
(pt)
|
1999-06-05 |
2002-03-12 |
Innovata Biomed Ltd |
Dispositivo de distribuição de medicamento,e,métodos de administrar um medicamento por inalação,e de,tratamento de um paciente com distúrbio respiratório
|
EP1210067A2
(de)
*
|
1999-08-25 |
2002-06-05 |
Advanced Inhalation Research, Inc. |
Modulation der freigabe aus trockenpulverformulierungen
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
US6156294A
(en)
*
|
1999-11-28 |
2000-12-05 |
Scientific Development And Research, Inc. |
Composition and method for treatment of otitis media
|
US6676930B2
(en)
|
1999-11-28 |
2004-01-13 |
Scientific Development And Research, Inc. |
Composition and method for treatment of otitis media
|
AU2729101A
(en)
*
|
1999-12-21 |
2001-07-03 |
Rxkinetix, Inc. |
Particulate drug-containing products and method of manufacture
|
US6761909B1
(en)
|
1999-12-21 |
2004-07-13 |
Rxkinetix, Inc. |
Particulate insulin-containing products and method of manufacture
|
RU2263672C2
(ru)
*
|
2000-02-11 |
2005-11-10 |
Рисерч Дивелопмент Фаундейшн |
Токоферолы, токотриенолы, другие хроманы и производные по боковым цепям и их применение
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
AU2001280934A1
(en)
*
|
2000-07-28 |
2002-02-13 |
Alliance Pharmaceutical Corp. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
US6613308B2
(en)
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
US6514482B1
(en)
|
2000-09-19 |
2003-02-04 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
EP1343372A2
(de)
|
2000-12-21 |
2003-09-17 |
Nektar Therapeutics |
Pulmonale verabreichung von polyene-antipilzmitteln
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
AU2002248366B2
(en)
*
|
2001-01-19 |
2006-10-26 |
Aeolus Sciences, Inc. |
Cancer therapy
|
MXPA03007017A
(es)
*
|
2001-02-06 |
2004-09-13 |
Innovata Biomed Ltd |
Medicamentos.
|
GB0102902D0
(en)
*
|
2001-02-06 |
2001-03-21 |
Innovata Biomed Ltd |
Medicaments
|
JP2005503425A
(ja)
*
|
2001-05-24 |
2005-02-03 |
アレックザ モレキュラー デリヴァリー コーポレイション |
所定の吸入ルートによる薬剤エステルの送出
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
US20070122353A1
(en)
*
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US6805853B2
(en)
*
|
2001-11-09 |
2004-10-19 |
Alexza Molecular Delivery Corporation |
Delivery of diazepam through an inhalation route
|
US20030051728A1
(en)
*
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
WO2002094240A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of physiologically active compounds through an inhalation route
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
WO2002094242A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of rizatriptan or zolmitriptan through an inhalation route
|
US7078016B2
(en)
|
2001-11-21 |
2006-07-18 |
Alexza Pharmaceuticals, Inc. |
Delivery of caffeine through an inhalation route
|
ATE415155T1
(de)
*
|
2001-05-24 |
2008-12-15 |
Alexza Pharmaceuticals Inc |
Verabreichung von alprazolam, estazolam, midazolam oder triazolam durch inhalation
|
US7458374B2
(en)
*
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
EP1439842A4
(de)
*
|
2001-06-01 |
2009-09-02 |
Nat Jewish Med & Res Center |
Oxidantienfänger zur behandlung von diabetes oder zur verwendung bei der transplantation oder induktion von immuntoleranz
|
US7125568B2
(en)
*
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
KR20040063901A
(ko)
*
|
2001-09-28 |
2004-07-14 |
에스페리온 테라피유틱스 인코포레이티드 |
고압에서 소포체를 압출하는 방법 및 장치
|
US8518437B2
(en)
*
|
2001-11-13 |
2013-08-27 |
Celator Pharmaceuticals, Inc. |
Lipid carrier compositions with enhanced blood stability
|
WO2003043603A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
WO2003043585A2
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Improved particulate compositions for pulmonary delivery
|
GB0128148D0
(en)
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
NZ533565A
(en)
*
|
2001-12-19 |
2006-11-30 |
Res Dev Foundation |
Liposomal delivery of vitamin E based anti-cancer compounds
|
US20030236301A1
(en)
*
|
2001-12-19 |
2003-12-25 |
Bob Sanders |
Liposomal delivery of vitamin E based compounds
|
WO2003075889A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Transave, Inc. |
An inhalation system for prevention and treatment of intracellular infections
|
WO2003075977A2
(en)
*
|
2002-03-05 |
2003-09-18 |
Cleveland State University |
Agglomerated particles for aerosol drug delivery
|
SI2630954T1
(sl)
*
|
2002-03-20 |
2017-02-28 |
Civitas Therapeutics, Inc. |
Pulmonalno dovajanje za levodopo
|
DE10214983A1
(de)
|
2002-04-04 |
2004-04-08 |
TransMIT Gesellschaft für Technologietransfer mbH |
Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
|
US20040009216A1
(en)
*
|
2002-04-05 |
2004-01-15 |
Rodrigueza Wendi V. |
Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
|
EP1503744A1
(de)
|
2002-05-13 |
2005-02-09 |
Alexza Molecular Delivery Corporation |
Verabreichung von aminenhaltigen arzneistoffen durch inhalation
|
US20060193788A1
(en)
*
|
2002-11-26 |
2006-08-31 |
Hale Ron L |
Acute treatment of headache with phenothiazine antipsychotics
|
US6930137B2
(en)
*
|
2002-05-31 |
2005-08-16 |
Fina Technology, Inc. |
Method of improving blown film processing performance and physical properties
|
EP1513537A4
(de)
*
|
2002-06-07 |
2006-09-06 |
Univ Duke |
Substituierte porphyrine
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
ES2539591T3
(es)
*
|
2002-10-29 |
2015-07-02 |
Insmed Incorporated |
Liberación sostenida de antiinfectantes
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
US7879351B2
(en)
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
US20040105818A1
(en)
*
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
JP2006514934A
(ja)
*
|
2002-11-26 |
2006-05-18 |
アレックザ ファーマシューティカルズ, インコーポレイテッド |
疼痛治療用薬剤製造のためのロキサピンまたはアモキサピンの使用
|
CA2507158A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Alexza Molecular Delivery Corporation |
Treatment of headache with antipsychotics delivered by inhalation
|
US7550133B2
(en)
*
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
US7913688B2
(en)
*
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
ATE510174T1
(de)
|
2003-05-21 |
2011-06-15 |
Alexza Pharmaceuticals Inc |
Schlag gezündete unabhängige heizeinheit
|
CA2527625A1
(en)
*
|
2003-05-30 |
2004-12-23 |
Alza Corporation |
Method of pulmonary administration of an agent
|
ATE473736T1
(de)
*
|
2003-12-16 |
2010-07-15 |
United Therapeutics Corp |
Verwendung von treprostinil zur behandlung von ischämischen läsionen
|
US20090124697A1
(en)
*
|
2003-12-16 |
2009-05-14 |
United Therapeutics Corporation |
Inhalation formulations of treprostinil
|
US7947741B2
(en)
*
|
2004-03-17 |
2011-05-24 |
Mpex Pharmaceuticals, Inc. |
Use and administration of bacterial efflux pump inhibitors
|
US7994225B2
(en)
*
|
2004-03-17 |
2011-08-09 |
Rempex Pharmaceuticals, Inc. |
Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
|
WO2005102429A1
(en)
*
|
2004-04-21 |
2005-11-03 |
Innovata Biomed Limited |
Inhaler
|
GB0409197D0
(en)
|
2004-04-24 |
2004-05-26 |
Innovata Biomed Ltd |
Device
|
US7540286B2
(en)
*
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
WO2006012502A2
(en)
*
|
2004-07-23 |
2006-02-02 |
Rigel Pharmaceuticals, Inc. |
Formulation of insoluble small molecule therapeutics in lipid-based carriers
|
EP1781360A1
(de)
*
|
2004-08-12 |
2007-05-09 |
Alexza Pharmaceuticals, Inc. |
Aerosol-arzneiabgabevorrichtung mit perkussiv aktivierten wärmepackungen
|
US20100006092A1
(en)
*
|
2004-08-12 |
2010-01-14 |
Alexza Pharmaceuticals, Inc. |
Aerosol Drug Delivery Device Incorporating Percussively Activated Heat Packages
|
US8337815B2
(en)
*
|
2004-12-23 |
2012-12-25 |
Discovery Laboratories, Inc. |
Pulmonary surfactant formulations
|
US20070031342A1
(en)
*
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
ATE458491T1
(de)
|
2005-08-26 |
2010-03-15 |
Univ Leland Stanford Junior |
Verfahren zur behandlung von kopfschmerzen durch verabreichung von oxytocin
|
JP2009518443A
(ja)
*
|
2005-12-06 |
2009-05-07 |
リゲル ファーマシューティカルズ インコーポレーティッド |
脂質を主材料とする担体に内封された、不溶性小分子治療剤の製剤
|
LT1962805T
(lt)
*
|
2005-12-08 |
2016-10-25 |
Insmed Incorporated |
Antiinfekcinės lipidų pagrindo kompozicijos, skirtos plaučių infekcijų gydymui
|
KR100795221B1
(ko)
|
2006-05-19 |
2008-01-17 |
한국화학연구원 |
암포테리신 β를 봉입하고 표면이 헤파린으로 수식된리포솜 및 그 제조 방법
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
WO2008112661A2
(en)
|
2007-03-09 |
2008-09-18 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
US11382895B2
(en)
|
2008-05-23 |
2022-07-12 |
National Jewish Health |
Methods for treating injury associated with exposure to an alkylating species
|
US8911711B2
(en)
*
|
2008-09-30 |
2014-12-16 |
The Invention Science Fund I, Llc |
Method, device, and system to control pH in pulmonary tissue of a subject
|
DE102009031274A1
(de)
|
2009-06-30 |
2011-01-13 |
Justus-Liebig-Universität Giessen |
Liposomen zur pulmonalen Applikation
|
EP2394640A1
(de)
|
2010-05-21 |
2011-12-14 |
MediGene AG |
Verbesserte liposomale Formulierungen von lipophilen Verbindungen
|
CN108743537B
(zh)
|
2012-05-21 |
2021-06-11 |
英斯麦德公司 |
治疗肺部感染的系统
|
RU2675859C2
(ru)
|
2012-11-29 |
2018-12-25 |
Инсмед Инкорпорейтед |
Стабилизированные составы ванкомицина
|
EP3142643B1
(de)
|
2014-05-15 |
2019-07-10 |
Insmed Incorporated |
Verfahren zur behandlung von pulmonaler mykobakterieller nichttuberkuloseinfektionen
|
PT3242676T
(pt)
|
2015-01-07 |
2023-12-06 |
TONIX Pharmaceuticals Holding Corp |
Formulações de ocitocina que contém magnésio e métodos de uso
|
WO2019191627A1
(en)
|
2018-03-30 |
2019-10-03 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
AU2019261329A1
(en)
|
2018-04-23 |
2020-11-12 |
Inspirmed Corp. |
Inhalable liposomal sustained release composition for use in treating pulmonary diseases
|